News

Filter

Current filters:

XareltoStivarga

Bayer foresees 8% pa sales growth for pharma through 2016

Bayer foresees 8% pa sales growth for pharma through 2016

13-03-2014

Germany’s Bayer expects strong growth for its pharmaceutical business as a result of a number of new…

AdempasBayerEyleaFinancialPharmaceuticalStivargaXareltoXofigo

Bayer initiates Ph III trail of Xarelto in cardiac event prevention; R&D day presentation

14-11-2012

German drug major Bayer (BAYN: DE) has initiated the Phase III COMPASS study of its oral anticoagulant…

AlpharadinBayerCardio-vascularOncologyOphthalmicsPharmaceuticalResearchStivargaXarelto

COMPANY SPOTLIGHT

Menarini

Back to top